CORC  > 湖南大学
Prevalence and current therapy in chronic liver disorders.
Muhammad Daniyal; Muhammad Akram; Rida Zainab; Naveed Munir; Aamir Sharif; Syed Muhammad Ali Shah; Bin Liu; Wei Wang
刊名Inflammopharmacology
2019
卷号Vol.27 No.2页码:213-231
关键词Allopathic medicine Efficacy Hepatoprotective activity Literature review Liver disorders Medicinal plants Side effects
ISSN号1568-5608
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4734659
专题湖南大学
作者单位TCM and Ethnomedicine Innovation and Development International Laboratory, School of Pharmacy, Innovative Materia Medica Research Institute, Hunan University of Chinese Medicine, Changsha, 410208, People's Republic of China. Department of Eastern Medicine, Directorate of Medical Sciences, Government College University, Faisalabad, Pakistan. Department of Eastern Medicine, Directorate of Medical Sciences, Government College University, Faisalabad, Pakistan. ridazainab357@gmail.com. Department of Biochemistry and College of Allied health professionals, Directorate of Medical sciences, Government College University, Faisalabad, Pakistan. Department of Pathology, Faculty of Medical and Health Sciences, University of Sargodha, Sargodha, Pakistan. Hunan Province Key Laboratory of Plant Functional Genomics and Developmental Regulation, College of Biology, Hunan University, Changsha, 410082, China.
推荐引用方式
GB/T 7714
Muhammad Daniyal,Muhammad Akram,Rida Zainab,et al. Prevalence and current therapy in chronic liver disorders.[J]. Inflammopharmacology,2019,Vol.27 No.2:213-231.
APA Muhammad Daniyal.,Muhammad Akram.,Rida Zainab.,Naveed Munir.,Aamir Sharif.,...&Wei Wang.(2019).Prevalence and current therapy in chronic liver disorders..Inflammopharmacology,Vol.27 No.2,213-231.
MLA Muhammad Daniyal,et al."Prevalence and current therapy in chronic liver disorders.".Inflammopharmacology Vol.27 No.2(2019):213-231.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace